Verified Nov 2026
Other
·

Zurich, Zurich
·
Since 1836
Acino is a Swiss pharmaceutical company headquartered in Zurich, founded in 1836, with 1,000–5,000 employees and estimated revenue of $500M–$1B. It develops and manufactures pharmaceuticals and biosimilar products for emerging markets across Africa, the Middle East, and Latin America. The company operates as a contract development and manufacturing organization, offering drug delivery technologies including modified-release formulations and transdermal patches. In July 2026, Acino partnered with Novo Nordisk to launch South Africa's first authorized semaglutide biosimilar.
Acino at a glance
Revenue
$500M-1B
Est. band
Employees
1,000-5,000
Founded
1836
Headquarters
Zurich, Zurich
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
Acino is a Swiss pharmaceutical company headquartered in Zurich, founded in 1836, with 1,000–5,000 employees and estimated revenue of $500M–$1B. It develops and manufactures pharmaceuticals and biosimilar products for emerging markets across Africa, the Middle East, and Latin America. The company operates as a contract development and manufacturing organization, offering drug delivery technologies including modified-release formulations and transdermal patches. In July 2026, Acino partnered with Novo Nordisk to launch South Africa's first authorized semaglutide biosimilar.
At a glance
Attribute | Detail |
|---|---|
Founded | 1836 |
Headquarters | Zurich, Zurich |
Employees | 1,000-5,000 |
Revenue | $500M-1B (estimated) |
What Acino makes
Acino manufactures novel drug delivery forms including modified-release oral formulations, transdermal patches, and biodegradable implants across therapeutic areas such as oncology, cardiology, and gastroenterology.
Products and capabilities described on the company's own site include Assembly, Plastic, Aluminum, Glass (source: acino.swiss).
Latest developments
2026-07-24 — Novo Nordisk and Acino partner to launch SA’s first authorised Semaglutide copy (kaya959.co.za)
2026-03-05 — Driving innovation, quality, and trust through digitalization in manufacturing | Acino (acino.swiss)
2026-01-16 — Ariprazol® Receives Qualification Release in the EU and Launches Sales in Latvia | Acino (acino.swiss)
2025-06-10 — AriBio and Arcera Sign Exclusive Licensing and Supply Agreements for Investigational Drug for Alzheimer’s Disease | Acino (acino.swiss)
2025-03-07 — HIIEKO renovated technical systems of Acino site in Põlva | Hiieko AS (hiieko.ee)
Company details
The company operates manufacturing facilities in Switzerland, Ukraine, Estonia, South Africa, and Dubai, serving healthcare systems and partnering with major pharmaceutical companies for contract manufacturing and product development. Acino was founded in 1836, has an estimated 1,000-5,000 employees, and is headquartered in Zurich, Zurich.
Frequently asked questions
What does Acino do?
Acino is a Swiss pharmaceutical company headquartered in Zurich, founded in 1836, with 1,000–5,000 employees and estimated revenue of $500M–$1B. It develops and manufactures pharmaceuticals and biosimilar products for emerging markets across Africa, the Middle East, and Latin America. The company operates as a contract development and manufacturing organization, offering drug delivery technologies including modified-release formulations and transdermal patches. In July 2026, Acino partnered with Novo Nordisk to launch South Africa's first authorized semaglutide biosimilar.
Where is Acino headquartered?
Acino is headquartered in Zurich, Zurich (36 Thurgauerstrasse, Zurich, Zurich, 8050).
When was Acino founded?
Acino was founded in 1836.
How big is Acino?
Acino has an estimated 1,000-5,000 employees, with revenue in the $500M-1B range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
